🦊/Companies

Corteneinc

1 known investors

Find your way into Corteneinc

59 people in our graph share verified history with the Corteneinc team — schools, employers, funds. One of them is your warm intro.

Robert Peaseunlockedknows Michael Corbett · together at Actuate Corporation (overlapped)
knows the team · via CRC Health Group
×2knows the team · via Infogain
×4knows the team · via Actuate Corporation
×4knows the team · via Curtin University

Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.

Founders & leadership

GP
Gerard PereirainFounder, President & CEO
SC
Sanjay ChandainChief Development Officer
MCMichael Corbett
Michael CorbettinChief Business OfficerMichael Corbett brings enterprise software architecture and business analysis expertise, with a background implementing large-scale applications across CRM, business intelligence, and system integration platforms including Salesforce and Cognos.

Investors · 1

Competitors · 2

by search overlap

Companies competing with Corteneinc for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Corteneinc do?
Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.
Who founded Corteneinc?
Corteneinc was founded by Gerard Pereira.
Who are Corteneinc's investors?
Corteneinc's investors include Lauder Partners.